Instem plc Grants Under the Long Term Incentive Plan (3702U)
July 29 2015 - 2:03AM
UK Regulatory
TIDMINS
RNS Number : 3702U
Instem plc
29 July 2015
Instem plc
("Instem")
Grants Under the Instem Long Term Incentive Plan ('LTIP')
Instem plc (AIM: INS), a leading provider of IT solutions to the
global early development healthcare market, announces that Chief
Executive Officer, Phil Reason has today been granted options over
150,000 ordinary shares of 10p each ("Ordinary Shares") and Chief
Financial Officer, Nigel Goldsmith has been granted options over
100,000 Ordinary Shares under the LTIP.
These share options will become exercisable in 2018, at the
nominal value of the Ordinary Shares, subject to meeting company
profit targets, pursuant to the rules of the LTIP, which was
approved by shareholders at the Annual General Meeting on 21 May
2013
Following these grants of options, Phil Reason and Nigel
Goldsmith hold a total of 360,856 and 175,000 share options,
respectively and their holdings in Ordinary Shares remain
unchanged.
For further information, please contact:
Instem plc Tel: +44 (0) 1785 825 600
Phil Reason, CEO www.instem.com
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser Tel: +44 (0) 20 7496 3000
& Broker)
Richard Lindley
Nick Owen
Walbrook PR Ltd Tel: +44 (0) 20 7933 8780 or
Paul Cornelius instem@walbrookpr.com
Sam Allen
Helen Cresswell
About Instem
Instem is a leading supplier of IT applications to the early
development healthcare market, delivering compelling solutions for
data collection, management and analysis across the R&D
continuum. Instem applications are in use by customers worldwide,
meeting the rapidly expanding needs of life science and healthcare
organizations for data-driven decision making leading to safer,
more effective products.
Instem's portfolio of software solutions increases client
productivity by automating study-related processes while offering
the unique ability to generate new knowledge through the extraction
and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in
the United States, United Kingdom and China with an additional
location in India and a full service distributor based in
Japan.
To learn more about Instem solutions and its mission, please
visit www.instem.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUWSRRVBABUUR
Instem (LSE:INS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Instem (LSE:INS)
Historical Stock Chart
From Jul 2023 to Jul 2024